59 related articles for article (PubMed ID: 18670261)
1. Contemporary Management of Risk Factors in Coronary Artery Disease (Part 1).
Tousoulis D; Theofilis P
Curr Pharm Des; 2023; 29(23):1801. PubMed ID: 37705168
[No Abstract] [Full Text] [Related]
2. Thulium Laser Vapoenucleation of the Prostate (ThuVEP) in Men at High Cardiovascular Risk and on Antithrombotic Therapy: A Single-Center Experience.
Castellani D; Di Rosa M; Gasparri L; Pucci M; Dellabella M
J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32230842
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Resistance Predicts Adverse Cardiovascular Events in Patients with Symptomatic Peripheral Artery Disease.
Pasala T; Hoo JS; Lockhart MK; Waheed R; Sengodan P; Alexander J; Gandhi S
Tex Heart Inst J; 2016 Dec; 43(6):482-487. PubMed ID: 28100965
[TBL] [Abstract][Full Text] [Related]
4. Low-dose acetylsalicylic acid for primary prevention of cardiovascular disease: Do not misinterpret the recommendations.
Truong C
Can Fam Physician; 2015 Nov; 61(11):971-5. PubMed ID: 26564657
[No Abstract] [Full Text] [Related]
5. Aspirin Action in Endothelial Cells: Different Patterns of Response Between Chemokine CX3CL1/CX3CR1 and TNF-α/TNFR1 Signaling Pathways.
Szukiewicz D; Wojciechowska M; Bilska A; Stangret A; Szewczyk G; Mittal TK; Watroba M; Kochanowski J
Cardiovasc Drugs Ther; 2015 Jun; 29(3):219-29. PubMed ID: 25959742
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention in nonagenarians: pros and cons.
Biondi Zoccai G; Abbate A; D'Ascenzo F; Presutti D; Peruzzi M; Cavarretta E; Marullo AG; Lotrionte M; Frati G
J Geriatr Cardiol; 2013 Mar; 10(1):82-90. PubMed ID: 23610578
[TBL] [Abstract][Full Text] [Related]
7. The management of patients on dual antiplatelet therapy undergoing orthopedic surgery.
Kim HJ; Levin LF
HSS J; 2010 Sep; 6(2):182-9. PubMed ID: 21886534
[TBL] [Abstract][Full Text] [Related]
8. The hazards of discontinuing acetylsalicylic acid therapy in those at risk of coronary artery disease.
Lotrionte M; Biondi-Zoccai GG
Curr Opin Cardiol; 2008 Sep; 23(5):487-93. PubMed ID: 18670261
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
10. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.
Bhatt DL
Am J Cardiol; 2009 Feb; 103(3 Suppl):11A-19A. PubMed ID: 19166708
[TBL] [Abstract][Full Text] [Related]
11. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
Motovska Z; Kala P
Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
[TBL] [Abstract][Full Text] [Related]
12. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence.
Lordkipanidzé M; Diodati JG; Pharand C
Pharmacol Ther; 2009 Aug; 123(2):178-86. PubMed ID: 19426760
[TBL] [Abstract][Full Text] [Related]
13. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
Dai X; Makaryus AN; Makaryus JN; Jauhar R
Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
